WBC
TMO icon

West Branch Capital’s Thermo Fisher Scientific TMO Stock Holding History

West Branch Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$144K Sell
287
-111
-28% -$53.3K 0.03% 95
2026
Q1 		$196K Sell
398
-1,699
-81% -$922K 0.05% 81
2025
Q4 		$1.22M Sell
2,097
-207
-9% -$117K 0.31% 43
2025
Q3 		$1.12M Sell
2,304
-395
-15% -$184K 0.29% 47
2025
Q2 		$1.09M Sell
2,699
-309
-10% -$129K 0.32% 47
2025
Q1 		$1.5M Buy
3,008
+296
+11% +$160K 0.5% 40
2024
Q4 		$1.41M Sell
2,712
-40
-1% -$22K 0.45% 39
2024
Q3 		$1.7M Buy
2,752
+68
+3% +$40.3K 0.59% 34
2024
Q2 		$1.48M Buy
2,684
+195
+8% +$112K 0.55% 35
2024
Q1 		$1.45M Buy
2,489
+339
+16% +$190K 0.58% 33
2023
Q4 		$1.14M Sell
2,150
-89
-4% -$43.1K 0.54% 33
2023
Q3 		$1.13M Buy
2,239
+138
+7% +$73.5K 0.59% 33
2023
Q2 		$1.1M Buy
2,101
+43
+2% +$23.2K 0.55% 33
2023
Q1 		$1.19M Buy
2,058
+5
+0.2% +$2.82K 0.66% 31
2022
Q4 		$1.13M Hold
2,053
– – 0.7% 32
2022
Q3 		$1.04M Sell
2,053
-42
-2% -$23.5K 0.65% 38
2022
Q2 		$1.14M Sell
2,095
-4
-0.2% -$2.2K 0.66% 38
2022
Q1 		$1.24M Sell
2,099
-94
-4% -$54K 0.59% 39
2021
Q4 		$1.46M Buy
2,193
+216
+11% +$135K 0.62% 37
2021
Q3 		$1.13M Buy
1,977
+37
+2% +$20.3K 0.54% 42
2021
Q2 		$979K Sell
1,940
-33
-2% -$15.6K 0.48% 44
2021
Q1 		$901K Sell
1,973
-60
-3% -$28.6K 0.53% 45
2020
Q4 		$947K Buy
2,033
+155
+8% +$72.7K 0.56% 44
2020
Q3 		$829K Buy
1,878
+277
+17% +$114K 0.53% 45
2020
Q2 		$580K Buy
+1,601
New +$537K 0.41% 53

Other funds holding TMO

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
QP
Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return

West Branch Capital's TMO Position: Q2 2026 in Review

West Branch Capital reduced its Thermo Fisher Scientific (TMO) stake by 28% in Q2 2026, selling an estimated $53.3K and leaving 287 shares worth $144K. The position accounts for 0.03% of the portfolio, ranked #95.

West Branch Capital first reported a position in TMO in Q2 2020 and has held it in 25 quarters since. The position peaked at $1.7M in Q3 2024. 794 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • West Branch Capital held 287 shares of Thermo Fisher Scientific worth $144K as of Q2 2026.
  • West Branch Capital sold 111 Thermo Fisher Scientific shares in Q2 2026, an estimated $53.3K.
  • Thermo Fisher Scientific made up 0.03% of West Branch Capital's portfolio in Q2 2026, its #95 holding.
  • West Branch Capital first reported a position in Thermo Fisher Scientific in Q2 2020 and has held it in 25 quarters since.
  • West Branch Capital's Thermo Fisher Scientific position peaked at $1.7M in Q3 2024.
  • 794 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on West Branch Capital's 13F filing for Q2 2026, filed 10 Jul 2026.